Evidence map›Paper›PMID 32973308›Full record

ArticleScientific reports2020

Prevalence and associated factors of hyperuricemia among urban adults aged 35-79 years in southwestern China: a community-based cross-sectional study.

Xiao-Bo Huang, Wen-Qiang Zhang, Wei-Wei Tang, Ya Liu, Yuan Ning, Chuan Huang, Jian-Xiong Liu, Yan-Jing Yi, Rong-Hua Xu, Tzung-Dau Wang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Evolving Landscape of Gout in the Female: A Narrative Review.Gout, urate, and crystal deposition disease · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Xiao-Bo Huang *Department of Cardiology, The Second People's Hospital of Chengdu, Chengdu, Sichuan, China.
Wen-Qiang Zhang *Department of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Wei-Wei Tang *School of Health Policy and Management, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Ya LiuDepartment of Endocrinology and Metabolism, Second People's Hospital of Chengdu, Chengdu, Sichuan, China.
Yuan NingDepartment of Endocrinology and Metabolism, Nanchong Central Hospital, Nanchong, Sichuan, China.
Chuan HuangDepartment of Cardiology, The Second People's Hospital of Chengdu, Chengdu, Sichuan, China.
Jian-Xiong LiuDepartment of Cardiology, The Second People's Hospital of Chengdu, Chengdu, Sichuan, China.
Yan-Jing YiDepartment of Geriatrics, Second People's Hospital of Chengdu, Chengdu, Sichuan, China.
Rong-Hua XuStroke Center, Second People's Hospital of Chengdu, Chengdu, Sichuan, China. cardiobo@sohu.com.
Tzung-Dau WangDivision of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan. tdwang@ntu.edu.tw.
Chengdu Second People's Hospital · CNNanchong Central Hospital · CNNanjing Medical University · CNNational Taiwan University Hospital · TWWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia is prevalent throughout the world. However, a well-designed large-scale epidemiological investigation of hyperuricemia in southwestern China is lacking. A regional representative sample of 10,141 participants were included using multistage, stratified sampling in Chengdu and Chongqing from September 2013 to March 2014. Hyperuricemia was defined as the self-reported of the doctor's diagnosis of hyperuricemia, or serum uric acid > 420 μmol/L in men or serum uric acid > 360 μmol/L in women. The overall age- and sex-standardized prevalence of hyperuricemia among adults aged 35-79 years was 13.5%. Compared with women, the prevalence of hyperuricemia in men was higher (17.3% versus 10.0%). Hypertension, hyperlipidemia, overweight or obesity, central obesity were associated with an increased risk for hyperuricemia both in men and in women. Married men and women were not susceptible to hyperuricemia. Current cigarette smoking was an associated risk factor of hyperuricemia only in women. Hyperuricemia has become a major health problem among urban adults aged 35-79 years in southwestern China, and special attention should be paid to men. Comorbidities associated with hyperuricemia and causality worth further investigation.

Indexed as

AdultAgedChinaComorbidityCross-Sectional StudiesFemaleHumansHyperuricemiaMaleMiddle AgedPrevalenceResidence CharacteristicsRisk FactorsUrban PopulationUric AcidUric Acid

Identifiers

PMID32973308
PMCPMC7515884
OpenAlexW3088110731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.